126 related articles for article (PubMed ID: 10373661)
1. Prognostic significance of serum LDH in Ewing's sarcoma of bone.
Bacci G; Ferrari S; Longhi A; Rimondini S; Versari M; Zanone A; Forni C
Oncol Rep; 1999; 6(4):807-11. PubMed ID: 10373661
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of serum lactic acid dehydrogenase in Ewing's tumor of bone.
Bacci G; Capanna R; Orlandi M; Mancini I; Bettelli G; Dallari D; Campanacci M
Ric Clin Lab; 1985; 15(1):89-96. PubMed ID: 3992134
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Bacci G; Ferrari S; Bertoni F; Rimondini S; Longhi A; Bacchini P; Forni C; Manfrini M; Donati D; Picci P
J Clin Oncol; 2000 Jan; 18(1):4-11. PubMed ID: 10623687
[TBL] [Abstract][Full Text] [Related]
4. Serum lactate dehydrogenase (LDH) as a tumor marker in Ewing's sarcoma.
Bacci G; Avella M; McDonald D; Toni A; Orlandi M; Campanacci M
Tumori; 1988 Dec; 74(6):649-55. PubMed ID: 3232209
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW
J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment serum lactate dehydrogenase predicting metastatic spread in Ewing's sarcoma.
Brereton HD; Simon R; Pomeroy TC
Ann Intern Med; 1975 Sep; 83(3):352-4. PubMed ID: 1180431
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
Hartman KR; Triche TJ; Kinsella TJ; Miser JS
Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
[TBL] [Abstract][Full Text] [Related]
9. Lactase dehydrogenase as a tumor marker for recurrent disease in Ewing's sarcoma.
Farley FA; Healey JH; Caparros-Sison B; Godbold J; Lane JM; Glasser DB
Cancer; 1987 Apr; 59(7):1245-8. PubMed ID: 3815300
[TBL] [Abstract][Full Text] [Related]
10. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
[TBL] [Abstract][Full Text] [Related]
11. Determination of prognostic factors and their influence on therapeutic results in patients with Ewing's sarcoma.
Glaubiger DL; Makuch R; Schwarz J; Levine AS; Johnson RE
Cancer; 1980 Apr; 45(8):2213-9. PubMed ID: 7370962
[TBL] [Abstract][Full Text] [Related]
12. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.
Baldini EH; Demetri GD; Fletcher CD; Foran J; Marcus KC; Singer S
Ann Surg; 1999 Jul; 230(1):79-86. PubMed ID: 10400040
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor in Ewing's sarcoma.
Kumar R; Sankineani S; Rastogi S; Prakash S; Bakhshi S; Sharma MC; Khan S; Sagar D C G; Rijal L
Int Orthop; 2012 Aug; 36(8):1669-72. PubMed ID: 22643796
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institution.
Aparicio J; Munárriz B; Pastor M; Vera FJ; Castel V; Aparisi F; Montalar J; Badal MD; Gómez-Codina J; Herranz C
Oncology; 1998; 55(1):20-6. PubMed ID: 9428371
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities.
Bacci G; Ferrari S; Sangiorgi L; Picci P; Casadei R; Orlandi M; Iantorno D; Battistini A; Zanone A
J Chemother; 1994 Jun; 6(3):204-10. PubMed ID: 7983504
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in Ewing's sarcoma of the foot.
Casadei R; Magnani M; Biagini R; Mercuri M
Clin Orthop Relat Res; 2004 Mar; (420):230-8. PubMed ID: 15057103
[TBL] [Abstract][Full Text] [Related]
17. Delayed diagnosis and tumor stage in Ewing's sarcoma.
Bacci G; Di Fiore M; Rimondini S; Baldini N
Oncol Rep; 1999; 6(2):465-6. PubMed ID: 10023023
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in children.
Luksch R; Sampietro G; Collini P; Boracchi P; Massimino M; Lombardi F; Gandola L; Giardini R; Fossati-Bellani F; Migliorini L; Pilotti S; Scopsi L
Tumori; 1999; 85(2):101-7. PubMed ID: 10363075
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
[TBL] [Abstract][Full Text] [Related]
20. Influence of prognostic factors on survival in Ewing's sarcoma.
Glaubiger DL; Makuch RW; Schwarz J
Natl Cancer Inst Monogr; 1981 Apr; (56):285-8. PubMed ID: 7300894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
